Stock Market Reviews

Read and share opinions on ENTO (Entero Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

Latest News

• Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy
  Nov 13, 2025
• Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid
  Nov 6, 2025
• Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)
  Oct 30, 2025
• Entero Regains Nasdaq Compliance With Grid AI Acquisition
  Oct 30, 2025
• Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid
  Oct 16, 2025
• From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)
  Oct 14, 2025
• Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It
  Oct 14, 2025
• ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI
  Oct 1, 2025
• ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand
  Oct 1, 2025
• Entero Therapeutics, Inc. (ENTO) Names Jason D. Sawyer as New CEO Amid Strategic Shift
  Sep 23, 2025
• Entero Therapeutics, Inc. Announces Reverse Stock Split
  Aug 14, 2025
• Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules
  Aug 11, 2025
• Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC
  Mar 25, 2025
• Entero Therapeutics Appoints Richard Paolone as CEO
  Feb 14, 2025
• Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members
  Feb 7, 2025